AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tipanat 8.19mg/20mg Tablet

Prescription Icon
Prescription Required

Marketer

Natco Pharma Ltd

Salt Composition

Tipiracil (8.19mg) + Trifluridine (20mg)

Overview Tipanat 8.19mg/20mg Tablet

Oncaspar 8.19mg/20mg tablets combine two medications to combat metastatic colorectal cancer. This treatment inhibits or retards cancerous cell proliferation. Administer Oncaspar with food, consistently at the same time daily for optimal effectiveness. Dosage and frequency are determined by your physician, contingent upon your specific condition and may be adjusted. Adhere strictly to prescribed instructions; improper use or overdose can lead to severe adverse reactions. Therapeutic benefits may not manifest for weeks or months; discontinue only under your doctor's guidance. Common side effects encompass anemia, neutropenia, fatigue, nausea, thrombocytopenia, reduced appetite, diarrhea, vomiting, and fever. Report any concerning side effects promptly. Regular blood tests monitor blood cell counts and liver function. Inform your healthcare provider of all other medications, as interactions may occur. This medication is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is crucial throughout treatment.

Uses of Tipanat 8.19mg/20mg Tablet

Colorectal cancer

Major Benefits of Tipanat 8.19mg/20mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Tipanat 8.19mg/20mg Tablet with a meal.

Common Side effects of Tipanat 8.19mg/20mg Tablet:

  • Anemia (low number of red blood cells)
  • Decreased white blood cell count (neutrophils)
  • Fatigue
  • Nausea
  • Low blood platelets
  • Decreased appetite
  • Diarrhea
  • Fever
  • Vomiting

How to use Tipanat 8.19mg/20mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Tipanat 8.19mg/20mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Tipanat 8.19mg/20mg Tablet works:

The dual-action anticancer tablet, Tipanat (8.19mg/20mg), combines trifluridine, which inhibits DNA replication and thus cancer cell proliferation, with tipiracil, which extends trifluridine's effectiveness by reducing its metabolic breakdown.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction of alcohol with Tipanat 8.19mg/20mg Tablet is unknown. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Tipanat 8.19mg/20mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingCAUTION

Administering Tipanat 8.19mg/20mg tablets to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.

DrivingDrivingCONSULT YOUR DOCTOR

The impact of Tipanat 8.19mg/20mg Tablet on driving ability is undetermined. Refrain from driving if any symptoms impair your concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

For patients with kidney disease, Tipanat 8.19mg/20mg tablets are considered safe to administer without any necessary dosage modification.

LiverLiverSAFE IF PRESCRIBED

Tipanat 8.19mg/20mg tablets may be administered to patients with hepatic impairment without alteration of the prescribed dosage.

What if you forget to take Tipanat 8.19mg/20mg Tablet :

Should you forget a Tipanat 8.19mg/20mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tipanat 8.19mg/20mg Tablet

LabelValue
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Tipanat 8.19mg/20mg Tablet

This medication can harm a developing fetus. Avoid pregnancy (for both men and women) during Tipanat 8.19mg/20mg Tablet treatment and for six months afterward. Discuss contraception with your doctor before starting treatment.
Breastfeeding should be discontinued during Tipanat 8.19mg/20mg Tablet treatment and for 24 hours after the last dose.
Soluble fiber, found in foods like ripe bananas, oranges, boiled potatoes, white rice, yogurt, and oatmeal, can help alleviate diarrhea by absorbing excess fluid. To combat diarrhea-related dehydration, aim for 8-10 glasses of water daily, supplementing with frequent sips of soup or juice.
Maintain your usual diet unless your doctor advises differently. Regular water intake is recommended to prevent dehydration. Consider frequent small, nutritious snacks instead of large meals, and hard candies or popsicles may help alleviate nausea and vomiting.
Continue this medication precisely as prescribed until your doctor instructs otherwise. Regular scans will monitor the tumor's response, with scheduling determined by your physician.
Tipanat 8.19mg/20mg Tablets reduce white blood cells and platelets, increasing your infection risk. Avoid contact with sick individuals. Seek immediate medical attention if you suspect an infection or develop fever, chills, or cough.
Low platelet counts can cause gum bleeding. Platelets are blood cells essential for blood clotting after injury.
Combating fatigue involves various strategies, including gentle exercise; however, consult your physician before starting any exercise program.
Tipanat 8.19mg/20mg Table...
8,640
MRP 10,000
13% off